Moderna CEO Stephane Bancel fumbled when asked why COVID-19 was found to contain a gene sequence patented by his company three years before the pandemic.
In a Thursday appearance on Fox Business’ “Mornings With Maria”, Bancel was asked by host Maria Bartiromo why a tiny chunk of DNA patented by Moderna was found in COVID-19.
“My scientists are looking into those data to see how accurate they are or not. As I’ve said before, the hypothesis of an escape from a lab by an accident is possible. Humans make mistakes,” Bancel admitted.
“So it is possible that the Wuhan lab in China was working on virus enhancement or gene modification, and then there’s an accident where somebody was infected in a lab and then infected family and friends.”
“It is possible on the claim you just mentioned. The scientists are analyzing to know if it’s real or not,” he added.
As we reported last week, a study published in Frontiers in Virology by an international team of researchers found that the SARS-CoV-2 furin cleavage site (FCS) contains genetic code identical to a part of a gene patented by Moderna in 2016.
The study noted the chances of Moderna’s patented gene sequence – called MSH3 – appearing naturally in the coronavirus is 1 in 3,000,000,000,000, meaning that this gene sequence occurring in COVID-19 through natural mutation is essentially impossible.
“The presence in SARS-CoV-2 of a 19-nucleotide RNA sequence encoding an FCS at amino acid 681 of its spike protein with 100% identity to the reverse complement of a proprietary MSH3 mRNA sequence is highly unusual,” the researchers noted.